Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

NCT03081481 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sophiris Bio Corp